United Therapeutics | UTHR - Assets


United Therapeutics reported $7.22B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Amarin USD 624.36M 21.4M Jun/2026
Ardelyx USD 504.51M 2.9M Mar/2026
Baxter International USD 19.79B 55M Jun/2026
Bayer EUR 107.94B 3.4B Mar/2026
BioCryst Pharmaceuticals USD 557.85M 92.8M Jun/2026
Biogen USD 32.09B 2.6B Jun/2026
BioMarin Pharmaceutical USD 8.59B 996.99M Mar/2026
Emergent BioSolutions USD 1.82B 69.9M Dec/2023
Gilead Sciences USD 49.36B 6.92B Jun/2026
GlaxoSmithKline GBP 61.74B 1.13B Jun/2026
Halozyme Therapeutics USD 2.67B 147.4M Mar/2026
Insmed USD 2.08B 188.7M Mar/2026
Ionis Pharmaceuticals USD 2.99B 455.5M Jun/2026
J&J USD 201.06B 167M Jun/2026
Lexicon Pharmaceuticals USD 268.82M 83.83M Mar/2026
Moderna USD 10.96B 527M Jun/2026
Omeros USD 200.57M 34.59M Jun/2025
Pfizer USD 201.13B 6.49B Jun/2026
PTC Therapeutics USD 3.25B 381.37M Jun/2026
Regeneron Pharmaceuticals USD 41.73B 861.8M Jun/2026
Sangamo BioSciences USD 97.56M 11.39M Jun/2025
Sarepta Therapeutics USD 3.18B 170.77M Mar/2026
Teva Pharmaceutical Industries USD 39.86B 183M Jun/2026
United Therapeutics USD 7.22B 505.9M Jun/2026
Vertex Pharmaceuticals USD 27.42B 938.9M Jun/2026